IMU 4.00% 4.8¢ imugene limited

Ann: First patient dosed in Phase 1 bile tract cancer trial, page-111

  1. 1,074 Posts.
    lightbulb Created with Sketch. 452
    Thanks for that. Interesting.

    Did you ask him what has in the combo arms? It seems possible they have either slowed or stopped as there has been no news on them this year that I'm aware of?

    mono IT cohort 5 cleared in April, and its seems IV mono has just cleared (and triggered the expansion trial to commence once the Cohort Review Committee cleared them?), which was mentioned further down in this ann.

    I note there are no forecast combo arm updates at all in the latest milestones forecast.

    GLTA.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.